SEC Form 4 · accession 0000950103-15-006642
BIO REFERENCE LABORATORIES INC · BRLI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Howard Dubinett
Officer — Executive VP, COO · Director
Period of report
Aug 20, 2015
Accepted (ET)
Aug 20, 2015 · 2:16 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000792641
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 20, 2015 | D | 345,138 | — | D | 0 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1As of the effective time of the transactions contemplated by the Agreement and Plan of Merger, dated as of June 3, 2015 (the "Merger Agreement"), by and among the Issuer, OPKO Health, Inc., a Delaware corporation ("OPKO"), and Bamboo Acquisition, Inc., a New Jersey corporation, each share of the Issuer's common stock held by the reporting person was disposed of pursuant to the Merger Agreement in exchange for 2.75 shares of OPKO common stock.